<p>The present disclosure relates to antibodies directed to the tumor necrosis factor alpha ("TNF-α") and uses of such antibodies, for example, to treat diseases associated with the activity and/or overproduction of TNF-α.</p>
申请公布号
AU2010236256(C1)
申请公布日期
2015.10.22
申请号
AU20100236256
申请日期
2010.04.16
申请人
ABBVIE BIOTHERAPEUTICS INC.
发明人
HARDING, FIONA A.;AKAMATSU, YOSHIKO;DUBRIDGE, ROBERT B.;POWERS, DAVID B.
